![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
CompTox Dashboard(EPA) | |
ECHA InfoCard | 100.164.315![]() |
Chemical and physical data | |
Formula | C12H11N3O |
Molar mass | 213.240 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
SIB-1757 is a drug used in scientific research which was one of the first compounds developed that acts as a selectiveantagonist for themetabotropic glutamate receptor subtypemGluR5.[1] It has anti-hyperalgesia effects in animals.[2] SIB-1757 along with other mGluR5 antagonists has been shown to have neuroprotective and hepatoprotective effects,[3][4] and it is also used to study the role of the mGluR5 receptor in brain development.[5]
![]() | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |